191 related articles for article (PubMed ID: 34686325)
1. NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions.
Cazzetta V; Bruni E; Terzoli S; Carenza C; Franzese S; Piazza R; Marzano P; Donadon M; Torzilli G; Cimino M; Simonelli M; Bello L; Villa A; Tan L; Ravens S; Prinz I; Supino D; Colombo FS; Lugli E; Marcenaro E; Vivier E; Della Bella S; Mikulak J; Mavilio D
Cell Rep; 2021 Oct; 37(3):109871. PubMed ID: 34686325
[TBL] [Abstract][Full Text] [Related]
2. Editorial: γδ T Cells in Cancer.
Coffelt SB; Kabelitz D; Silva-Santos B; Kuball J; Born W; Bank I
Front Immunol; 2020; 11():602411. PubMed ID: 33329597
[No Abstract] [Full Text] [Related]
3. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
Rong L; Li K; Li R; Liu HM; Sun R; Liu XY
World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849
[TBL] [Abstract][Full Text] [Related]
4. Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors.
Park JH; Kim HJ; Kim CW; Kim HC; Jung Y; Lee HS; Lee Y; Ju YS; Oh JE; Park SH; Lee JH; Lee SK; Lee HK
Nat Immunol; 2021 Mar; 22(3):336-346. PubMed ID: 33574616
[TBL] [Abstract][Full Text] [Related]
5. Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8
Abd Hamid M; Wang RZ; Yao X; Fan P; Li X; Chang XM; Feng Y; Jones S; Maldonado-Perez D; Waugh C; Verrill C; Simmons A; Cerundolo V; McMichael A; Conlon C; Wang X; Peng Y; Dong T
Cancer Immunol Res; 2019 Aug; 7(8):1293-1306. PubMed ID: 31213473
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
7. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
Kamiya T; Seow SV; Wong D; Robinson M; Campana D
J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
[TBL] [Abstract][Full Text] [Related]
8. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.
Angelini DF; Zambello R; Galandrini R; Diamantini A; Placido R; Micucci F; Poccia F; Semenzato G; Borsellino G; Santoni A; Battistini L
J Leukoc Biol; 2011 Jan; 89(1):75-84. PubMed ID: 20952657
[TBL] [Abstract][Full Text] [Related]
9. Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release.
Park JA; Santich BH; Xu H; Lum LG; Cheung NV
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986124
[TBL] [Abstract][Full Text] [Related]
10. CD16
Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy.
Hsu H; Boudova S; Mvula G; Divala TH; Rach D; Mungwira RG; Boldrin F; Degiacomi G; Manganelli R; Laufer MK; Cairo C
Cell Immunol; 2021 Jan; 359():104244. PubMed ID: 33248366
[TBL] [Abstract][Full Text] [Related]
12. γδ T cells in cancer immunotherapy.
Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
[TBL] [Abstract][Full Text] [Related]
13. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
[TBL] [Abstract][Full Text] [Related]
14. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
[TBL] [Abstract][Full Text] [Related]
15. Immunoactivation in preeclampsia: Vdelta2+ and regulatory T cells during the inflammatory stage of disease.
Miko E; Szereday L; Barakonyi A; Jarkovich A; Varga P; Szekeres-Bartho J
J Reprod Immunol; 2009 Jun; 80(1-2):100-8. PubMed ID: 19395088
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals.
Ryan PL; Sumaria N; Holland CJ; Bradford CM; Izotova N; Grandjean CL; Jawad AS; Bergmeier LA; Pennington DJ
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14378-14383. PubMed ID: 27911793
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.
Cordova A; Toia F; La Mendola C; Orlando V; Meraviglia S; Rinaldi G; Todaro M; Cicero G; Zichichi L; Donni PL; Caccamo N; Stassi G; Dieli F; Moschella F
PLoS One; 2012; 7(11):e49878. PubMed ID: 23189169
[TBL] [Abstract][Full Text] [Related]
18. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
[TBL] [Abstract][Full Text] [Related]
19. Permanent silencing of NKG2A expression for cell-based therapeutics.
Figueiredo C; Seltsam A; Blasczyk R
J Mol Med (Berl); 2009 Feb; 87(2):199-210. PubMed ID: 19002424
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells.
Sacchi A; Tumino N; Sabatini A; Cimini E; Casetti R; Bordoni V; Grassi G; Agrati C
Front Immunol; 2018; 9():1271. PubMed ID: 29928279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
